BIOCON LTD. - U.S. FDA Accepts Biologies License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review

Biocon Ltd has informed BSE regarding a Press Release dated February 16, 2017, titled "U.S. FDA Accepts Biologies License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review".